finasteride
UkraineDrugs containing this active substance
-
The drug is prescribed for the treatment and control of benign prostatic hyperplasia (adenoma). It helps to reduce the size of the gland, improve urine flow, reduce symptoms, and lower the risk of acute urinary retention or the need for surgical intervention.
Form: tablets, film-coated
Active substance Dosage finasteride 5 mg ATC: G04CB01
Manufacturer: LLC "Corporation "Zdorovya" (all manufacturing stages, quality control, batch release)
-
The drug is used for the treatment and control of benign prostatic hyperplasia (BPH). It helps to reduce the size of the enlarged gland, improve urine flow, reduce symptoms, and lower the risk of acute urinary retention or the need for surgical intervention.
Form: tablets, film-coated
Active substance Dosage finasteride 5 mg ATC: G04CB01
Manufacturer: Hetero Labs Limited
-
The drug is used for the treatment and control of benign prostatic hyperplasia (BPH). It helps to reduce the size of the gland, improve urine flow, reduce symptoms, and lower the risk of acute urinary retention or the need for surgical intervention.
Form: tablets, film-coated
Active substance Dosage finasteride 5 mg ATC: G04CB01
Manufacturer: Aurobindo Pharma Limited - Unit III
-
The drug is intended for the treatment and management of benign prostatic hyperplasia (BPH). It helps to reduce the size of the enlarged prostate, improve urine flow, alleviate symptoms, and reduce the risk of acute urinary retention or the need for surgical intervention.
Form: tablets, film-coated
Active substance Dosage finasteride 5 mg ATC: G04CB01
Manufacturer: Genepharm S.A.
-
The drug is used for the treatment and control of benign prostatic hyperplasia (adenoma). It helps to reduce the size of the gland, improve urine flow, reduce symptoms, and lower the risk of acute urinary retention or the need for surgical intervention.
Form: tablets, film-coated
Active substance Dosage finasteride 5 mg ATC: G04CB01
Manufacturer: Zentiva, Inc.
-
The drug is used for the treatment and control of benign prostatic hyperplasia. It helps to reduce the size of the gland, improve urine flow, reduce symptoms, and lower the risk of acute urinary retention or the need for surgical intervention.
Form: tablets, film-coated
Active substance Dosage finasteride 5 mg ATC: G04CB01
Manufacturer: PJSC "Tekhnolog"